Search Tag: ESC guidelines

Cardiology Management


2014 01 Sep

This year's ESC Congress will see the launch of five new ESC Guidelines: Non-Cardiac Surgery, Acute Pulmonary Embolism, Hypertrophic Cardiomyopathy, Aortic Diseases and Myocardial Revascularization. The first was developed jointly with the European Society of Anesthesiology and the last with the European Society of Thoracic Surgery. The guidelines...Read more

Cardiology Management


2014 02 Sep

One of the most important treatment principles in cardiology includes myocardial revascularisation by percutaneous coronary intervention (PCI) or surgical placement of coronary artery bypass grafts (CABG). However, in order to use these principles effectively, it is important to identify patients who require revascularisation as well as accurately...Read more

Cardiology Management


2015 17 Feb

Coronary patients in Europe are not meeting lifestyle, therapeutic and risk factor targets after hospitalisation A new approach to the secondary prevention of coronary disease is called for The large majority of coronary patients in Europe are failing to achieve their lifestyle, risk factor and therapeutic targets as set out in the latest prevention...Read more

Cardiology Management


2019 24 Jan

There is significant clinical evidence that suggests a strong association between low-density lipoprotein (LDL)-cholesterol with risk of coronary artery disease (CAD) events and the reduction of cardiovascular events in secondary prevention. Based on this evidence, the European Society of Cardiology incorporated low-density lipoprotein targets...Read more

Cardiology Management


2019 03 Sep

At the ESC Congress this year, several new guidelines have been released including updated guidelines on lipid control and new guidelines on diabetes and cardiovascular disease.  As per the updated guidelines on lipid control ,  the following are some key recommendations:  Low-density lipoprotein (LDL) cholesterol levels should be lowered...Read more

Executive Health Management


2019 02 Oct

Summary: A presentation of a case study in light of the updated ESC guidelines on lipid control and new guidelines on diabetes and cardiovascular disease. Several new guidelines were released at the European Society of Cardiology (ESC) Congress in Paris, France. These included updated guidelines on lipid control and new guidelines...Read more

ICU Management


2021 30 Sep

In 2020, the ultra-short acting beta-blocker landiolol was first included in the ESC guidelines with a class I recommendation. The recommendations were based on study results demonstrating the rapid response, efficacy, and safety of this drug. At a recent symposium, during 2021 Heart Failure World Congress, cardiologists were invited to present...Read more

Cardiology Management


2022 15 Feb

The new ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure outline ten key messages: The guidelines recommend an angiotensin-converting enzyme inhibitor or angiotensin receptor-neprilysin inhibitor, a beta-blocker, a mineralocorticoid receptor antagonist, and a sodium-glucose co-transporter 2 inhibitor to reduce...Read more